CC BY-NC 4.0 · Arch Plast Surg 2012; 39(01): 18-24
DOI: 10.5999/aps.2012.39.1.18
Original Article

Management of Infections with Rapidly Growing Mycobacteria after Unexpected Complications of Skin and Subcutaneous Surgical Procedures

Jong Min Lim
Department of Plastic and Reconstructive Surgery, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea
,
Jong Hwan Kim
Department of Plastic and Reconstructive Surgery, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea
,
Ho Jik Yang
Department of Plastic and Reconstructive Surgery, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea
› Author Affiliations

Background Infection caused by rapidly growing mycobacteria (RGM) is not uncommon, and the prevalence of RGM infection has been increasing. Clinical diagnosis is difficult because there are no characteristic clinical features. There is also no standard antibiotic regimen for treating RGM infection. A small series of patients with RGM infections was studied to examine their treatments and outcomes.

Methods A total of 5 patients who had developed postoperative infections from January 2009 to December 2010 were retrospectively reviewed. Patients were initially screened using a mycobacteria rapid screening test (polymerase chain reaction [PCR]-reverse blot hybridization assay). To confirm mycobacterial infection, specimens were cultured for nontuberculous mycobacteria and analyzed by 16 S ribosomal RNA and rpoB gene PCR.

Results The patients were treated with intravenous antibiotics during hospitalization, and oral antibiotics were administered after discharge. The mean duration of follow-up was 9 months, and all patients were completely cured of infection with a regimen of a combination of antibiotics plus surgical treatment. Although none of the patients developed recurrence, there were complications at the site of infection, including hypertrophic scarring, pigmentation, and disfigurement.

Conclusions Combination antibiotic therapy plus drainage of surgical abscesses appeared to be effective for the RGM infections seen in our patients. Although neither the exact dosage nor a standardized regimen has been firmly established, we propose that our treatment can provide an option for the management of rapidly growing mycobacterial infection.



Publication History

Received: 15 August 2011

Accepted: 23 November 2011

Article published online:
01 May 2022

© 2012. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Dailloux M, Laurain C, Weber M. et al. Water and nontuberculous mycobacteria. Water Res 1999; 33: 2219-2228
  • 2 Muthusami JC, Vyas FL, Mukundan U. et al. Mycobacterium fortuitum: an iatrogenic cause of soft tissue infection in surgery. ANZ J Surg 2004; 74: 662-666
  • 3 Jarzembowski JA, Young MB. Nontuberculous mycobacterial infections. Arch Pathol Lab Med 2008; 132: 1333-1341
  • 4 Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Infections with rapidly growing mycobacteria: report of 20 cases. Int J Infect Dis 2003; 7: 198-205
  • 5 Galea LA, Nicklin S. Mycobacterium abscessus infection complicating hand rejuvenation with structural fat grafting. J Plast Reconstr Aesthet Surg 2009; 62: e15-e16
  • 6 Murillo J, Torres J, Bofill L. et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol 2000; 136: 1347-1352
  • 7 Molecules and Diagnostics Incorporation. REBA Myco-ID product manual. 2009. Wonju, KR: Molecules and Diagnostics Incorporation;
  • 8 Adekambi T, Stein A, Carvajal J. et al. Description of Mycobacterium conceptionense sp. nov., a Mycobacterium fortuitum group organism isolated from a posttraumatic osteitis inflammation. J Clin Microbiol 2006; 44: 1268-1273
  • 9 Shin S, Kim EC, Yoon JH. Identification of nontuberculous mycobacteria by sequence analysis of the 16S ribosomal RNA, the heat-shock protein 65 and the RNA polymerase beta-subunit genes. Korean J Lab Med 2006; 26: 153-160
  • 10 Kim BJ, Lee SH, Lyu MA. et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 1999; 37: 1714-1720
  • 11 Wallace Jr RJ, Brown BA, Silcox VA. et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J Infect Dis 1991; 163: 598-603
  • 12 Brown-Elliott BA, Wallace Jr RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002; 15: 716-746
  • 13 Kim HR, Kim DW. Soft tissue infection with Mycobacterium abscessus on the chin of a healthy child: a case report. J Korean Soc Plast Reconstr Surg 2010; 37: 289-292